Treatment Effect of Tofacitinib, Adalimumab Compared in RA

WEDNESDAY, July 12, 2023 -- For adults with rheumatoid arthritis (RA), there is a modest reduction in the mean Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) at three months for patients receiving tofacitinib (TOF) versus...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news